KALA BIO, Inc. (KALA)
NASDAQ·Healthcare·Biotechnology
$0.56
—
Mkt Cap $10.42M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.25
Range $1.50 – $35.00
Implied Upside
+3146.2%
Consensus $18.25 vs current $0.56
NASDAQ·Healthcare·Biotechnology
$0.56
—
Mkt Cap $10.42M
No recent rating data.
Price Target (5 analysts)
$18.25
Range $1.50 – $35.00
+3146.2%
Consensus $18.25 vs current $0.56